Star Health and Allied Insurance Company Limited accepted the resignation of Mr. Utpal Sheth as Nominee Director representing the estate of Late Mr. Rakesh Jhunjunwala, effective June 26, 2026. The resignation follows the transmission of 8,28,82,958 Equity Shares previously held by Late Mr. Rakesh Jhunjunwala and the subsequent withdrawal of nomination by the estate. Consequently, the Board appointed Mr. Utpal Hemendra Sheth as an Additional Director under the Non-Executive category representing Sitara Partners LLP, the Promoter, effective June 26, 2026, subject to member approval.

The Board also recorded the retirement of two Independent Directors. Mr. Rajeev Krishnamuralilal Agarwal and Ms. Rajni Sekhri Sibal will retire from the close of business hours on July 15, 2026, upon completion of their term of five consecutive years. The Board expressed its appreciation for their contributions during their tenure.

The transmission of shares was executed based on a Probate issued by the Honourable High Court of Bombay on December 18, 2023. The appointment of Mr. Sheth as Additional Director representing Sitara Partners LLP was approved by IRDAI on April 06, 2026. He is slated to serve as Nominee Director representing Sitara Partners LLP subject to the approval of the members.

Mr. Sheth is the Founder and Mentor of Trust Group and Chanakya Wealth Creation. He previously served as the Chief Executive Officer and Senior Partner of Rare Enterprises. With a career spanning over 35 years, he possesses extensive experience in investment management, fund raising, M&A, and corporate advisory. The Board confirmed that Mr. Sheth is not related to any other Director of the Company and is not debarred from holding the office of Director by SEBI or any other authority.

Key Board Changes

Star Health and Allied Insurance Company Limited will meet analysts and institutional investors in London on June 29, 2026, to present its Q4FY26 performance and strategic outlook. The insurer will engage with five major investment firms, including Jupiter Asset Management and Schroder Investment Management, to update stakeholders on recent financial results.

The meeting follows Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Due to business exigencies on the part of the investors, the company provided intimation at a shorter notice than usual. Star Health expressed regret for the short notice and committed to ensuring timely intimation for future meetings.

The schedule includes in-person sessions with the following firms:

The presentation for the meeting will be made available on the company's website. The disclosure is subject to changes that may occur due to exigencies on the part of the analysts or investors.